The Remarkable Life of Ibelin, a documentary on Netflix, explains how a terminally ill boy found freedom in World of Warcraft ...

The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

Tommy was given a tour of the Bills facility in his hometown and met with head coach Sean McDermott as part of his ...

The co-owner, Chad Day, has been a part of the fundraising efforts for the six-year-old with Duchenne muscular dystrophy.

Researchers have demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides, another class ...

ABEL Motorsports driver Callum Hedge (photo) is trying to raise awareness and funds to combat muscular dystrophy in his ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

This year's Futures National Conference, hosted by CureDuchenne for the Duchenne and Becker MD communities, is scheduled to ...

The orphan drug designation is particularly noteworthy as it can provide Dyne with a range of benefits, including reduced regulatory fees, assistance with clinical protocols, eligibility for research ...

Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for ...

Dyne Therapeutics (DYN) announced that the European Commission has granted orphan drug designation for DYNE-251 for the treatment of Duchenne ...